- Home
- DCTH vs DXYZ Comparison
DCTH vs DXYZ Comparison
Compare DCTH & DXYZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DCTH
- DXYZ
- Stock Information
- Founded
- DCTH 1988
- DXYZ N/A
- Country
- DCTH United States
- DXYZ
- Employees
- DCTH N/A
- DXYZ N/A
- Industry
- DCTH Medical/Dental Instruments
- DXYZ
- Sector
- DCTH Health Care
- DXYZ
- Exchange
- DCTH Nasdaq
- DXYZ Nasdaq
- Market Cap
- DCTH 387.2M
- DXYZ 350.2M
- IPO Year
- DCTH N/A
- DXYZ 2024
- Fundamental
- Price
- DCTH $10.91
- DXYZ $61.81
- Analyst Decision
- DCTH Strong Buy
- DXYZ
- Analyst Count
- DCTH 4
- DXYZ 0
- Target Price
- DCTH $21.50
- DXYZ N/A
- AVG Volume (30 Days)
- DCTH 375.2K
- DXYZ N/A
- Earning Date
- DCTH 11-08-2024
- DXYZ N/A
- Dividend Yield
- DCTH N/A
- DXYZ N/A
- EPS Growth
- DCTH N/A
- DXYZ N/A
- EPS
- DCTH N/A
- DXYZ N/A
- Revenue
- DCTH $22,644,000.00
- DXYZ N/A
- Revenue This Year
- DCTH $1,605.13
- DXYZ N/A
- Revenue Next Year
- DCTH $111.67
- DXYZ N/A
- P/E Ratio
- DCTH N/A
- DXYZ N/A
- Revenue Growth
- DCTH 945.91
- DXYZ N/A
- 52 Week Low
- DCTH $3.43
- DXYZ N/A
- 52 Week High
- DCTH $13.30
- DXYZ N/A
- Technical
- Relative Strength Index (RSI)
- DCTH 57.95
- DXYZ N/A
- Support Level
- DCTH $11.67
- DXYZ N/A
- Resistance Level
- DCTH $13.30
- DXYZ N/A
- Average True Range (ATR)
- DCTH 0.73
- DXYZ 0.00
- MACD
- DCTH 0.01
- DXYZ 0.00
- Stochastic Oscillator
- DCTH 34.60
- DXYZ 0.00
About DCTH Delcath Systems Inc.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.
About DXYZ Destiny Tech100 Inc. Common Stock
Destiny Tech100 Inc is a non-diversified, closed-end management investment company. It invests in a portfolio of what is believed to be 100 of the top venture-backed private technology companies.